Your browser doesn't support javascript.
loading
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.
Giantonio, B J; Levy, D E; O'dwyer, P J; Meropol, N J; Catalano, P J; Benson, A B.
Affiliation
  • Giantonio BJ; University of Pennsylvania, Philadelphia, PA 19104, USA. giantonio.bruce@jimmy.harvard.edu
Ann Oncol ; 17(9): 1399-403, 2006 Sep.
Article in En | MEDLINE | ID: mdl-16873427
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy Type of study: Clinical_trials Limits: Aged80 Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy Type of study: Clinical_trials Limits: Aged80 Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido